Hormonal Predictors of Oncologic Surgery

The Association of Hypogonadism and Post-operative Outcomes of Oncologic Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02471157

Acronym

HPOS

Enrollment

200

Registered

2015-06-15

Start date

2015-01-31

Completion date

2016-10-31

Last updated

2019-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypogonadism

Brief summary

An observational trial to determine whether preoperative hormonal status predicts outcomes of oncologic surgery.

Interventions

OTHERObservation

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* Undergoing above surgery for cancer

Exclusion criteria

* Started hormonal replacement in past two months

Design outcomes

Primary

Measure	Time frame	Description
Length of Stay	6 days, on average	Length of post-operative stay
Complication rate, post-operative	6 days, on average	Complication rate during initial postoperative period
Complication rate, 30 day	30 days	Complication rate during the initial 30 days after surgery
Complication rate, 90 days	90 days	Complication rate during the initial 90 days after surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026